Cancer immunotherapy with immunomodulatory anti-CD137 and anti–PD-1 monoclonal antibodies requires BATF3-dependent dendritic cells

1. Sánchez-Paulete, A.R.
2. Cueto, F.J.
3. Martínez-López, M.
4. Labiano, S.
5. Morales-Kastresana, A.
6. Rodríguez-Ruiz, M.E.
7. Jure-Kunkel, M.
8. Azpilikueta, A.
9. Aznar, M.A.
10. Quetglas, J.I.
11. Sancho, D.
12. Melero, I.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1158/2159-8290.CD-15-0510 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus